1. Home
  2. MIST vs CTM Comparison

MIST vs CTM Comparison

Compare MIST & CTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • CTM
  • Stock Information
  • Founded
  • MIST 2003
  • CTM 2019
  • Country
  • MIST Canada
  • CTM United States
  • Employees
  • MIST N/A
  • CTM N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • CTM EDP Services
  • Sector
  • MIST Health Care
  • CTM Technology
  • Exchange
  • MIST Nasdaq
  • CTM Nasdaq
  • Market Cap
  • MIST 132.5M
  • CTM 119.9M
  • IPO Year
  • MIST N/A
  • CTM N/A
  • Fundamental
  • Price
  • MIST $1.70
  • CTM $1.04
  • Analyst Decision
  • MIST Strong Buy
  • CTM Strong Buy
  • Analyst Count
  • MIST 2
  • CTM 1
  • Target Price
  • MIST $7.50
  • CTM $3.00
  • AVG Volume (30 Days)
  • MIST 938.8K
  • CTM 2.7M
  • Earning Date
  • MIST 08-12-2025
  • CTM 08-08-2025
  • Dividend Yield
  • MIST N/A
  • CTM N/A
  • EPS Growth
  • MIST N/A
  • CTM N/A
  • EPS
  • MIST N/A
  • CTM N/A
  • Revenue
  • MIST N/A
  • CTM $47,595,866.00
  • Revenue This Year
  • MIST N/A
  • CTM $22.97
  • Revenue Next Year
  • MIST N/A
  • CTM $3.76
  • P/E Ratio
  • MIST N/A
  • CTM N/A
  • Revenue Growth
  • MIST N/A
  • CTM 4.17
  • 52 Week Low
  • MIST $0.63
  • CTM $0.13
  • 52 Week High
  • MIST $2.75
  • CTM $2.83
  • Technical
  • Relative Strength Index (RSI)
  • MIST 54.42
  • CTM 40.00
  • Support Level
  • MIST $1.62
  • CTM $0.95
  • Resistance Level
  • MIST $1.75
  • CTM $1.32
  • Average True Range (ATR)
  • MIST 0.08
  • CTM 0.08
  • MACD
  • MIST 0.02
  • CTM -0.02
  • Stochastic Oscillator
  • MIST 82.76
  • CTM 24.32

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About CTM Castellum Inc.

Castellum Inc is engaged in providing information technology services. The company provides financial services, healthcare, and other users of large data applications with services that include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and MBSE. In addition to constantly innovating and enhancing organic capabilities, Castellum is acquiring technology companies in the areas of cybersecurity, information technology, electronic warfare, information warfare, and information operations with businesses in the defense, federal, civilian, and commercial markets.

Share on Social Networks: